ANAEROBE 2022: the 16th Biennial Congress of the Anaerobe Society of the Americas (ASA)

厌氧菌 2022:第 16 届美洲厌氧菌协会 (ASA) 双年度大会

基本信息

  • 批准号:
    10464618
  • 负责人:
  • 金额:
    $ 0.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-22 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary Anaerobes, bacteria that thrive in the absence of oxygen, are major contributors to both disease and health in humans. While Clostridioides difficile is a serious infectious disease threat and a leading cause of healthcare- associated infections, there are many other anaerobic bacterial pathogens that contribute to suffering and death. Conversely, some anaerobes contribute in a beneficial way to the structure and function of the human microbiome and are associated with health. Although regional Societies focused on anaerobe bacterial science have existed in the past in select locales abroad (e.g., Britain, Japan), the Anaerobe Society of the Americas (ASA) is the only continuously active society and the only United States-based Society devoted to the basic and clinical science of anaerobes. Further, the ASA maintains an active international membership, with representation from more than 31 countries at the 2020 Biennial Congress, which was conducted as a virtual program due to the COVID-19 pandemic. The long-term goal of the ASA and its biennial congress (founded in 1992) is to promote health and advance science through the study of anaerobic bacteria and their environments. This proposal seeks NIH support for ANAEROBE 2022, the 16th Biennial Congress of the ASA, which will be hosted as a hybrid meeting from July 28-31, 2022 in Seattle, WA. The specific aims of the 16th Biennial Congress are to: (1) stimulate interest in anaerobes among trainees, promote networking among anaerobists from all disciplines, and foster strong mentoring relationships through substantive opportunities for trainee participation including a poster session, early-career investigator awards, and our featured breakout session on publishing led by an editor of a major journal; (2) facilitate scientific interchange and demonstrate for trainees how divergent opinions in science are encouraged and discussed via a featured debate; (3) explore the roles of indigenous anaerobes in promoting human health and discuss recent insights into disease induction by anaerobic bacteria including C. difficile and Fusobacteria; (4) accelerate anaerobe research by facilitating methodological advances in culture techniques, genetic manipulation, and model systems; and (5) examine up-to-date clinical management strategies for anaerobic infections and probe emerging mechanisms of action, health benefits, and regulatory issues associated with clinical microbiota transfer. The 16th Biennial Congress will accomplish this goal through presentations by more than 70 domestic and international scientific speakers and a variety of presentation formats, including the option to attend in-person or virtually. In creating the program for ANAEROBE 2022, the Organizing Committee has prioritized diversity and inclusion among participants and attendees. The focused, synergistic program will encourage hearty interdisciplinary exchange between scientists who do not generally congregate in any other conference. Consistent with the goals of the NIH and NIAID, the 16th Biennial Congress of the ASA provides a unique opportunity to bring together the world’s leading basic and clinical investigators in anaerobe bacterial science to advance studies with lasting impact on human health.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID Neal FREDRICKS其他文献

DAVID Neal FREDRICKS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID Neal FREDRICKS', 18)}}的其他基金

Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation
粪便微生物群移植和纤维治疗造血细胞移植后移植物抗宿主病
  • 批准号:
    10737446
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10668432
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10220681
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Prospective Epidemiologic Study of Novel Etiologic Agents of Pelvic Inflammatory Disease
盆腔炎新病因的前瞻性流行病学研究
  • 批准号:
    10471222
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10593458
  • 财政年份:
    2017
  • 资助金额:
    $ 0.5万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10287495
  • 财政年份:
    2017
  • 资助金额:
    $ 0.5万
  • 项目类别:
The Gut Microbiota and Graft versus Host Disease (GVHD)
肠道微生物群和移植物抗宿主病 (GVHD)
  • 批准号:
    10053303
  • 财政年份:
    2017
  • 资助金额:
    $ 0.5万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    8672151
  • 财政年份:
    2014
  • 资助金额:
    $ 0.5万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    9001246
  • 财政年份:
    2014
  • 资助金额:
    $ 0.5万
  • 项目类别:
Male urethritis: Novel etiologies and natural history
男性尿道炎:新的病因和自然史
  • 批准号:
    8815259
  • 财政年份:
    2014
  • 资助金额:
    $ 0.5万
  • 项目类别:

相似海外基金

Maturation and resolution of Staphylococcus aureus skin abscess
金黄色葡萄球菌皮肤脓肿的成熟和消退
  • 批准号:
    MR/Y000447/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Fellowship
S. aureus virulence factor expression during kidney abscess formation
肾脓肿形成过程中金黄色葡萄球菌毒力因子的表达
  • 批准号:
    10610817
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
S. aureus virulence factor expression during kidney abscess formation
肾脓肿形成过程中金黄色葡萄球菌毒力因子的表达
  • 批准号:
    10370868
  • 财政年份:
    2022
  • 资助金额:
    $ 0.5万
  • 项目类别:
Characterization of T7SS in S. intermedius isolated from brain abscess to blood-brain barrier disruption
从脑脓肿分离到血脑屏障破坏的中间链球菌中 T7SS 的特征
  • 批准号:
    20K16257
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10385790
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10025874
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10190942
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Combinational therapy with antibiotics and antibiotic-loaded adipose-derived stem cells reduce abscess formation in implant-related infection in rats
抗生素和负载抗生素的脂肪干细胞联合治疗可减少大鼠植入相关感染中脓肿的形成
  • 批准号:
    20K18057
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Optical property measurement in human abscess cavities for photodynamic therapy treatment planning
人体脓肿腔光学特性测量,用于光动力疗法治疗计划
  • 批准号:
    10611934
  • 财政年份:
    2020
  • 资助金额:
    $ 0.5万
  • 项目类别:
Exploratory research for new methodology of diagnosis and treatments of gynecological pelvic abscess using MR Spectroscopy and Identification of bacteria species by NGS.
使用磁共振波谱和NGS鉴定细菌种类的妇科盆腔脓肿诊断和治疗新方法的探索性研究。
  • 批准号:
    18K16779
  • 财政年份:
    2018
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了